Evidence map›Paper›PMID 40924404›Full record

ArticleBriefings in bioinformatics2025

Multi-layer matrix factorization for cancer subtyping using full and partial multi-omics dataset.

Yingxuan Ren, Fengtao Ren, Bo Yang

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yingxuan RenNational University of Singapore, 119077, Singapore.
Fengtao RenDepartment of Engineering, The Chinese University of Hong Kong, 999077, Hong Kong, China.
Bo YangSchool of Computer Science, Xi'an Polytechnic University, 710048, Xi'an, China.ORCID 0000-0001-6200-8727

Funding

Natural Science Basic Research Program of Shaanxi 2024JC-YBMS-473
6 · The paper itself

Abstract

Cancer, with its inherent heterogeneity, is commonly categorized into distinct subtypes based on unique traits, cellular origins, and molecular markers specific to each type. However, current studies primarily rely on complete multi-omics datasets for predicting cancer subtypes, often overlooking predictive performance in cases where some omics data may be missing and neglecting implicit relationships across multiple layers of omics data integration. This paper introduces Multi-Layer Matrix Factorization (MLMF), a novel approach for cancer subtyping that employs multi-omics data clustering. MLMF initially processes multi-omics feature matrices by performing multi-layer linear or nonlinear factorization, decomposing the original data into latent feature representations unique to each omics type. These latent representations are subsequently fused into a consensus form, on which spectral clustering is performed to determine subtypes. Additionally, MLMF incorporates a class indicator matrix to handle missing omics data, creating a unified framework that can manage both complete and incomplete multi-omics data. Extensive experiments conducted on 12 multi-omics cancer datasets, both complete and with missing values, demonstrate that MLMF achieves results that are comparable to or surpass the performance of several state-of-the-art approaches. MLMF is open source and available at (https://github.com/renyingxuan/MLMF.git).

Indexed as

Computational BiologyGenomicsNeoplasmsAlgorithmsCluster AnalysisHumansMultiomicscancer subtypingmatrix factorizationmissing datamulti-omics data

Identifiers

PMID40924404
PMCPMC12418959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.